| MOZOBIL GENZYME CORPORATION
1490770 30 Jul 2010 | on 12 Apr 2012 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical and medicinal preparations for the treatment of HIV, inflammation, arthritis, asthma, cancer, cell transplants and cell transplant rejection, organ transplants and organ transplant rejection, angiogenesis, multiple sclerosis, bacterial infection, peripheral blood stem cell mobilization, cardiovascular diseases, lymphoma, tissue regeneration, tissue repair, leukemia, drug-induced anemia, retrovirus, hematopoietic deficit resulting from chemotherapy or radiation therapy, elevation of white blood cells, and opthamalic diseases, including age related macular degeneration and diabetic retinopathy. | | | MOZOBIL GENZYME CORPORATION
1219832 09 Jun 2004 | on 08 Sep 2010 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical and medicinal preparations for the treatment of HIV, inflammation, arthritis, asthma, cancer, cell transplants and cell transplant rejection, organ transplants and organ transplant rejection, angiogenesis, multiple sclerosis, bacterial infection, peripheral blood stem cell mobilization, cardiovascular diseases, lymphoma, tissue regeneration, tissue repair, leukemia, drug-induced anemia, retrovirus, hematopoietic deficit resulting from chemotherapy or radiation therapy, elevation of white blood cells, and opthamalic diseases, including age related macular degeneration and diabetic retinopathy. | | | MOZOBIL DESIGN GENZYME CORPORATION
1247380 15 Feb 2005 | on 03 Sep 2008 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical and medicinal preparations for the treatment of HIV, inflammation, arthritis, asthma, cancer, cell transplants and cell transplant rejection, organ transplants and organ transplant rejection, angiogenesis, multiple sclerosis, bacterial infection, peripheral blood stem cell mobilization, cardiovascular diseases, lymphoma, tissue regeneration, tissue repair, leukemia, drug-induced anemia, retrovirus, hematopoietic deficit resulting from chemotherapy or radiation therapy, elevation of white blood cells, and opthamalic diseases, including age related macular degeneration and diabetic retinopathy. | |